Market Cap 209.86M
Revenue (ttm) 10.09M
Net Income (ttm) -130.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,288.80%
Debt to Equity Ratio 0.00
Volume 356,700
Avg Vol 541,992
Day's Range N/A - N/A
Shares Out 12.17M
Stochastic %K 8%
Beta 1.78
Analysts Strong Sell
Price Target $67.00

Company Profile

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for...

Industry: Biotechnology
Sector: Healthcare
Phone: 862 799 8599
Fax: 862 904 8163
Address:
26 Main Street, Suite 101, Chatham, United States
JuggernautRaider
JuggernautRaider Feb. 3 at 10:18 PM
Yes. $TNXP already has $1.4M in net sales in the first three weeks of January matching what they had, and I’ll be sharing updates weekly as I get them. If things go well we may surpass $100M in Q4 alone 🚀 Just remember: the street values this asset as worth nothing 😂 My estimates: Q1: $18M net sales Q2: $45M net sales Q3: $72M net sales Q4: $99M net sales Monthly breakdown (assuming linear growth of $3M net sales increases per month): January: $3M net sales February: $6M net sales March: $9M net sales April: $12M net sales May: $15M net sales June: $18M net sales July: $21 M net sales August: $24 M net sales September: $27M net sales October: $30M net sales November: $33M net sales December: $36M net sales
1 · Reply
Josemi67
Josemi67 Feb. 3 at 10:04 PM
$TNXP Hemos batido expectativas y terminado en rojo. Alguien me puede decir que espera el mercado? Porque de momento la evolución de la cotización sigue siendo pésima por mucho que nos pese a los alcistas.
2 · Reply
JuggernautRaider
JuggernautRaider Feb. 3 at 9:06 PM
$TNXP today’s selloff was a huge buying opportunity. Tonmya has sold as much in the first three weeks of the year as it did in all of Q4! ($1.4M!) This launch compares favorably to recent launches in CNS - Point72 picked up on it and took a 10% stake in the company. GLB ☘️ 🐂
2 · Reply
Allstar81
Allstar81 Feb. 3 at 8:55 PM
$TNXP Did they just beat earning expectations x14?!
0 · Reply
Crystalgiorda1976
Crystalgiorda1976 Feb. 3 at 8:55 PM
$TNXP sold $ 1.4 millions from the 17th of november till the end of the year. Someone shared some calculations estimating $28 millions of revenues regarding Tonmya that means losing 70/80 million dollars in 2026. I think we are gonna go down to 7 or 8 dollars this year
1 · Reply
RyaKelly
RyaKelly Feb. 3 at 7:41 PM
$TNXP deep microcap under the radar watching for speculative volume ignition
0 · Reply
C4Trading
C4Trading Feb. 3 at 6:52 PM
$TNXP 30% increase in revenue YoY with only 6 weeks of Tonmya launch on the books. Next year it will be 3000% increase. Hold and accumulate.
1 · Reply
carronsbfc
carronsbfc Feb. 3 at 6:45 PM
$TNXP The short thesis “they sell shares because the drug doesn’t sell” is broken. Tonmya is selling. January shows no meaningful dilution. Cash is strong, revenue is real, and the narrative has flipped. From here, it’s no longer about IF Tonix sells the drug. It’s about how fast it ramps.
1 · Reply
StockJayC
StockJayC Feb. 3 at 6:39 PM
$TNXP Early release of prelim financials !! Management is comfortable with the outcome so not expecting any surprises on actuals! This is great for enabling forward planning for projections of Tonmya sales and attracting new investors! Bring on 2026 and a strong Q1 !
0 · Reply
Himan93
Himan93 Feb. 3 at 6:31 PM
$TNXP TNXP is the next BINI, especially to all people who are still bullish
1 · Reply
Latest News on TNXP
Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

Dec 9, 2025, 7:00 AM EST - 2 months ago

Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel


Tonix Q3 2025 Earnings Recap And Tonmya Launch Outlook

Nov 14, 2025, 9:41 AM EST - 2 months ago

Tonix Q3 2025 Earnings Recap And Tonmya Launch Outlook


Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025

Oct 28, 2025, 7:00 AM EDT - 3 months ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025


Tonix Secures Fibromyalgia Approval - What Investors Should Know

Aug 16, 2025, 8:45 AM EDT - 6 months ago

Tonix Secures Fibromyalgia Approval - What Investors Should Know


Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion?

Jun 13, 2025, 7:30 AM EDT - 8 months ago

Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion?


JuggernautRaider
JuggernautRaider Feb. 3 at 10:18 PM
Yes. $TNXP already has $1.4M in net sales in the first three weeks of January matching what they had, and I’ll be sharing updates weekly as I get them. If things go well we may surpass $100M in Q4 alone 🚀 Just remember: the street values this asset as worth nothing 😂 My estimates: Q1: $18M net sales Q2: $45M net sales Q3: $72M net sales Q4: $99M net sales Monthly breakdown (assuming linear growth of $3M net sales increases per month): January: $3M net sales February: $6M net sales March: $9M net sales April: $12M net sales May: $15M net sales June: $18M net sales July: $21 M net sales August: $24 M net sales September: $27M net sales October: $30M net sales November: $33M net sales December: $36M net sales
1 · Reply
Josemi67
Josemi67 Feb. 3 at 10:04 PM
$TNXP Hemos batido expectativas y terminado en rojo. Alguien me puede decir que espera el mercado? Porque de momento la evolución de la cotización sigue siendo pésima por mucho que nos pese a los alcistas.
2 · Reply
JuggernautRaider
JuggernautRaider Feb. 3 at 9:06 PM
$TNXP today’s selloff was a huge buying opportunity. Tonmya has sold as much in the first three weeks of the year as it did in all of Q4! ($1.4M!) This launch compares favorably to recent launches in CNS - Point72 picked up on it and took a 10% stake in the company. GLB ☘️ 🐂
2 · Reply
Allstar81
Allstar81 Feb. 3 at 8:55 PM
$TNXP Did they just beat earning expectations x14?!
0 · Reply
Crystalgiorda1976
Crystalgiorda1976 Feb. 3 at 8:55 PM
$TNXP sold $ 1.4 millions from the 17th of november till the end of the year. Someone shared some calculations estimating $28 millions of revenues regarding Tonmya that means losing 70/80 million dollars in 2026. I think we are gonna go down to 7 or 8 dollars this year
1 · Reply
RyaKelly
RyaKelly Feb. 3 at 7:41 PM
$TNXP deep microcap under the radar watching for speculative volume ignition
0 · Reply
C4Trading
C4Trading Feb. 3 at 6:52 PM
$TNXP 30% increase in revenue YoY with only 6 weeks of Tonmya launch on the books. Next year it will be 3000% increase. Hold and accumulate.
1 · Reply
carronsbfc
carronsbfc Feb. 3 at 6:45 PM
$TNXP The short thesis “they sell shares because the drug doesn’t sell” is broken. Tonmya is selling. January shows no meaningful dilution. Cash is strong, revenue is real, and the narrative has flipped. From here, it’s no longer about IF Tonix sells the drug. It’s about how fast it ramps.
1 · Reply
StockJayC
StockJayC Feb. 3 at 6:39 PM
$TNXP Early release of prelim financials !! Management is comfortable with the outcome so not expecting any surprises on actuals! This is great for enabling forward planning for projections of Tonmya sales and attracting new investors! Bring on 2026 and a strong Q1 !
0 · Reply
Himan93
Himan93 Feb. 3 at 6:31 PM
$TNXP TNXP is the next BINI, especially to all people who are still bullish
1 · Reply
royalwingo
royalwingo Feb. 3 at 6:29 PM
$TNXP don’t be bullied by low volume volatility ! Yes, it’s depressing, but don’t sell 💎
1 · Reply
ByBi
ByBi Feb. 3 at 6:21 PM
$TNXP there we are at the low of day, at roughly the same time as everyday. Now i would expect those large off exchange volumes to kick in
0 · Reply
Rungreen
Rungreen Feb. 3 at 6:20 PM
$TNXP interesting there’s 82,818 watchers here and it looks like it’s going to be a red day after this positive news. Go figure.
0 · Reply
Kaki10
Kaki10 Feb. 3 at 6:14 PM
$TNXP 🤣🤣🤣🤣🤣🤣🤣🤣
0 · Reply
StavStocks
StavStocks Feb. 3 at 5:43 PM
0 · Reply
Andi77
Andi77 Feb. 3 at 5:34 PM
$TNXP The market is red🤷‍♂️
0 · Reply
Proposition_Joe
Proposition_Joe Feb. 3 at 5:29 PM
$TNXP to those posting that Seth has been non-stop diluting in January, we have our answer: he has not. I posted a while back when the Point72 offering was completed that Tonix was barred from selling shares for 30 days with some exceptions, but it wasn’t clear if the ATM was an exception to that covenant. Per today’s 8k we get a fresh view of shares outstanding as of Jan 30th, and it is only 5,883 shares more than after the Point72 deal Was completed. The Point72 deal was completed at the end of December, so there may have only been 1 day the ATM could be used (I.e. 1/30/26), and only 5,883 shares were issued. My guess is some portion of daily cash use is covered with the ATM based on some set point share price. What’s good about that, is with Tonmya sales quickly ramping, it should minimize even small drips of ATM…but we really don’t know. I’m just piecing together the data points we do have. But one thing is clear: there was not “nonstop dilution” in January.
1 · Reply
carronsbfc
carronsbfc Feb. 3 at 5:18 PM
$TNXP The 8-K closed one chapter, but it didn’t open the next one yet. Today’s filing proved Tonix is no longer pre-revenue. What the market is waiting for now is “direction”. The next PR or 8-K is the important one. The one that talks about pace, not just presence: about how fast Tonmya is ramping. That kind of update typically comes before the March earnings call, not during it. Late January through mid-February is the logical window if management wants to guide expectations rather than let the market guess. This phase is about patience. ⏳
1 · Reply
tyty22
tyty22 Feb. 3 at 5:05 PM
$TNXP well at least we know the drug is out there and sales are beginning to pick up. This is just the tip of the iceberg. Positive movement is on its way and we’ll see $60 by mid year.
1 · Reply
asweidan
asweidan Feb. 3 at 4:53 PM
$TNXP Just an observation. In the last 6 months we have not had only 4 red days in a row. We had 5,6,1,2,3 but never 4. If we finish green today that would be a change. We started to head down early today. So I am hoping that we have enough time to reverse the trend and finish early.
1 · Reply
Kaki10
Kaki10 Feb. 3 at 4:47 PM
$TNXP lol red Coming 🤣🤣🤣
0 · Reply
hofno2003
hofno2003 Feb. 3 at 4:32 PM
$TNXP 8K- do your math - $16.33 / share cash at year end. "Company ended the year with approximately $207.6 million in cash and cash equivalents. As of January 30, 2026, the Company had 12,793,952 shares of common stock outstanding."
1 · Reply